![]() |
Breast Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the
Era of Adjuvant CDK4/6 Inhibitors.
Am J Clin Oncol. 2025;48:357-361.
PubMed
Abstract available
Retraction Notice to "Insulin-Induced Gene 2 Expression Is Associated with Breast
Cancer Metastasis" [Am J Pathol 191 (2021) 385-395].
Am J Pathol. 2025;195:1358.
PubMed
Association between travel burden and surgical timeliness for women with breast
cancer in Georgia.
Am J Surg. 2025;247:116484.
PubMed
Abstract available
Identifying resource needs of patients with breast cancer by examining alignment
of Reddit post content with BREAST-Q domains.
Am J Surg. 2025;247:116486.
PubMed
Abstract available
Trends in axillary staging for breast cancer in the elderly: Outcomes of choosing
wisely at a high-usage institution.
Am J Surg. 2025;250:116477.
PubMed
Abstract available
Letter Re: A phase III trial of adjuvant ribociclib plus endocrine therapy versus
endocrine therapy alone in patients with HR-positive/HER2-negative early breast
cancer: final invasive disease-free survival results from the NATALEE trial.
Ann Oncol. 2025 Jun 20:S0923-7534(25)00816-6. doi: 10.1016/j.annonc.2025.
PubMed
Navigating the Limits of Ribociclib in Early Breast Cancer: Questions from the
NATALEE Trial.
Ann Oncol. 2025 Jun 23:S0923-7534(25)00815-4. doi: 10.1016/j.annonc.2025.
PubMed
Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and
Worse Survival in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17657.
PubMed
Abstract available
Lymphatic Contrast-enhanced Ultrasound as a Noninvasive Predictor of Sentinel
Lymph Node Metastasis in Breast Cancer: A Prospective Diagnostic Study.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17705.
PubMed
Abstract available
ASO Visual Abstract: Intraoperative Radiation Therapy (IORT) for Breast Cancer:
The Final Analysis of a Prospective Cohort of 1828 Cases.
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17698.
PubMed
Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph
Node Dissection in Breast Cancer: The FARM Trial.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17703.
PubMed
Abstract available
ASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage
Breast Cancer.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17732.
PubMed
A Dose-Image Optimization Trial for Voluven(R)-Assisted Indocyanine Green
Fluorescence-Guided Breast Cancer Sentinel Lymph Node Surgery.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17696.
PubMed
Abstract available
Unlocking New Frontiers in Breast Cancer: The Role of the Tumor Microenvironment,
Cutting-Edge Therapies, and Immunotherapy.
Anticancer Res. 2025;45:2729-2747.
PubMed
Abstract available
Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer:
Knowledge, Management and Characterization in the IOPS-MS Study.
Anticancer Res. 2025;45:3149-3164.
PubMed
Abstract available
Reduced duration adjuvant trastuzumab in the treatment of patients with
HER2-positive breast cancer: a meta-analysis of randomised controlled
non-inferiority trials including IPD data.
BMJ Oncol. 2025;4:e000810.
PubMed
Abstract available
Comparison of transcriptome profiles of radiotherapy beams on MCF-7 breast cancer
xenografts.
Breast Cancer. 2025 Jun 27. doi: 10.1007/s12282-025-01735.
PubMed
Abstract available
KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog
signaling pathway.
Breast Cancer. 2025 Jun 24. doi: 10.1007/s12282-025-01737.
PubMed
Abstract available
Correction: Real?world evidence from Japan regarding survival outcomes and
treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy
as first? or second?line treatment for hormone receptor-positive, HER2?negative
advanced or met
Breast Cancer. 2025 Jun 23. doi: 10.1007/s12282-025-01736.
PubMed
Systemic glucocorticoids and the risk of breast cancer in a large nationwide
case-control study.
Breast Cancer Res. 2025;27:114.
PubMed
Abstract available
Correction: Targeting tumour re-wiring by triple blockade of mTORC1, epidermal
growth factor, and oestrogen receptor signalling pathways in endocrine-resistant
breast cancer.
Breast Cancer Res. 2025;27:116.
PubMed
Combined prognostic impact of initial clinical stage and residual cancer burden
after neoadjuvant systemic therapy in triple-negative and HER2-positive breast
cancer: an analysis of the I-SPY2 randomized clinical trial.
Breast Cancer Res. 2025;27:115.
PubMed
Abstract available
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a
marker of the metastatic phenotype in breast cancer.
Breast Cancer Res. 2025;27:112.
PubMed
Abstract available
Anti-cancer drug sensitivity testing and preclinical evaluation of the
anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer
patient-derived organoids and xenograft models.
Breast Cancer Res. 2025;27:113.
PubMed
Abstract available
The use of indocyanine green and technetium-99 for dual-tracer sentinel lymph
node biopsy in breast cancer.
Breast Cancer Res Treat. 2025 Jun 27. doi: 10.1007/s10549-025-07767.
PubMed
Abstract available
Analysis of the impact of the COVID-19 pandemic on the stage at diagnosis in
breast cancer patients at a French comprehensive cancer centre, through two
different methods: a preliminary study.
Breast Cancer Res Treat. 2025 Jun 27. doi: 10.1007/s10549-025-07762.
PubMed
Abstract available
Trastuzumab therapy and new-onset hypertension in adolescents and young adults
with breast cancer.
Breast Cancer Res Treat. 2025 Jun 27. doi: 10.1007/s10549-025-07760.
PubMed
Abstract available
The deltopectoral lymph node: a potential protective biomarker for breast
cancer-related lymphedema.
Breast Cancer Res Treat. 2025 Jun 25. doi: 10.1007/s10549-025-07748.
PubMed
Abstract available
Area deprivation index and breast cancer outcomes among patients in Western New
York.
Breast Cancer Res Treat. 2025 Jun 22. doi: 10.1007/s10549-025-07733.
PubMed
Abstract available
Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic
metastatic breast cancer female patients: a randomized controlled trial.
Cancer Chemother Pharmacol. 2025;95:64.
PubMed
Abstract available
Letter to the Editor Regarding the Article "In Triple-Negative Breast Cancer:
Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of
Neoadjuvant Chemotherapy".
Clin Breast Cancer. 2025 May 30:S1526-8209(25)00147.
PubMed
Distribution of HER2 Low in Tumors of Patients With Hereditary Breast Cancer
According to Germline Pathogenic or Likely Pathogenic Genetic Variants.
Clin Breast Cancer. 2025 May 28:S1526-8209(25)00148.
PubMed
Abstract available
Disparities in Access to Multigene Testing in Early-Stage, HR-positive,
HER2-negative, Lymph Node-negative Breast Cancer.
Clin Breast Cancer. 2025 May 24:S1526-8209(25)00149.
PubMed
Abstract available
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage
I-IV Breast Cancer.
Clin Breast Cancer. 2025 May 27:S1526-8209(25)00161.
PubMed
Abstract available
FOXC1 expression predicts capecitabine efficacy in triple-negative breast cancer
patients from the GEICAM_CIBOMA trial.
Clin Cancer Res. 2025 Jun 26. doi: 10.1158/1078-0432.CCR-25-0338.
PubMed
Abstract available
Tumor volume as a predictor of recurrence-free survival, but not overall
survival, in early breast cancer.
Eur J Surg Oncol. 2025;51:110024.
PubMed
Abstract available
A retrospective study evaluating surgical upstaging rates in low-risk DCIS
patients meeting the eligibility criteria for active surveillance trials.
Eur J Surg Oncol. 2025;51:109716.
PubMed
Abstract available
Validation of a simulator for oncoplastic breast conserving surgery.
Eur J Surg Oncol. 2025;51:109753.
PubMed
Abstract available
The evaluation of artificial intelligence in mammography-based breast cancer
screening: Is breast-level analysis enough?
Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11733.
PubMed
Abstract available
Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring
response to neoadjuvant therapy in breast cancer.
Eur Radiol. 2025 Jun 24. doi: 10.1007/s00330-025-11640.
PubMed
Abstract available
TLR-4 genetic variants as predictive biomarkers for susceptibility and clinical
outcomes in triple-negative breast cancer: A case control study.
Gene. 2025;964:149643.
PubMed
Abstract available
Expression of the lncRNA NEAT1/hsa-miR-20b-5p/STAT3 axis in breast cancer.
Gene. 2025;964:149638.
PubMed
Abstract available
Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor
histology.
Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.70025.
PubMed
Abstract available
Patient-reported outcome thresholds and their associations with survival, adverse
events, and quality of life in a pooled analysis of breast cancer trials.
Int J Cancer. 2025 Jun 21. doi: 10.1002/ijc.70020.
PubMed
Abstract available
Risk of breast cancer among women with hypo- and hyperthyroidism: Results from a
large nationwide cohort study.
Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70007.
PubMed
Abstract available
Feasibility and Impact of a Radiation Therapy Technologist-Driven Workflow for
Cone Beam Computed Tomography Guided Partial Breast Adaptive Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:893-901.
PubMed
Abstract available
HSD3B1 Upregulation via LRH1 Sustains Estrogen Receptor Signaling and Promotes
Endocrine Resistance in Breast Cancer.
J Biol Chem. 2025 Jun 20:110405. doi: 10.1016/j.jbc.2025.110405.
PubMed
Abstract available
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant
breast cancer.
J Biol Chem. 2025 Jun 24:110414. doi: 10.1016/j.jbc.2025.110414.
PubMed
Abstract available
A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact
of Insurance Coverage on Risk Reduction.
J Surg Oncol. 2025;131:1393-1399.
PubMed
Abstract available
Improving the Evaluation of Aesthetic Outcomes in DIEP Flap Breast
Reconstruction: Validation of the Aesthetic Grading Tool.
J Surg Oncol. 2025;131:1407-1412.
PubMed
Abstract available
Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing
Affect Clinical and Patient-Reported Outcomes?
J Surg Oncol. 2025;131:1400-1406.
PubMed
Abstract available
Epitrochlear and Humeral Lymph Nodes: A Biomarker for Deep Lymphatic Function and
Implications for Breast Cancer-Related Lymphedema Risk.
J Surg Oncol. 2025 Jun 24. doi: 10.1002/jso.70002.
PubMed
Abstract available
Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for
an anthracycline-containing regimen in patients with breast cancer: a phase 3,
double-blind, randomised, placebo-controlled trial.
Lancet Oncol. 2025 Jun 17:S1470-2045(25)00233.
PubMed
Abstract available
Personalized neoadjuvant strategy using 70-gene assay to increase
breast-conserving surgery in ER+/HER2- breast cancer.
NPJ Breast Cancer. 2025;11:57.
PubMed
Abstract available
Biomarkers of palbociclib response in hormone receptor-positive advanced breast
cancer from the PARSIFAL trial.
NPJ Breast Cancer. 2025;11:59.
PubMed
Abstract available
Personalized mutation tracking in circulating-tumor DNA predicts recurrence in
patients with high-risk early breast cancer.
NPJ Breast Cancer. 2025;11:58.
PubMed
Abstract available
A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic
estrogen receptor positive breast cancer.
NPJ Breast Cancer. 2025;11:61.
PubMed
Abstract available
Cross-field strength and multi-vendor reliability of MagDensity for MRI-based
quantitative breast density analysis.
PLoS One. 2025;20:e0316076.
PubMed
Abstract available
Multi-site validation of an interpretable model to analyze breast masses.
PLoS One. 2025;20:e0320091.
PubMed
Abstract available
The test-retest reliability of the H-Reflex and swaymeter in women aged 30-65
years.
PLoS One. 2025;20:e0314437.
PubMed
Abstract available
Futility in healthcare among Mexican female patients with breast cancer in
advanced stage: The patient perspective.
PLoS One. 2025;20:e0326332.
PubMed
Abstract available
Improving the robustness and efficiency of cell sheet protocol for breast cancer
induction in animal model: A Geltrex plus Gelatin approach.
PLoS One. 2025;20:e0326456.
PubMed
Abstract available
Solid breast tumors phantom emulating oxy and deoxyhemoglobin concentrations for
near infrared imaging.
PLoS One. 2025;20:e0325768.
PubMed
Abstract available
Outcomes of complex decongestive therapy in managing upper limb lymphedema in
female breast cancer patients at a palliative care unit of a tertiary care
hospital in Bangladesh.
PLoS One. 2025;20:e0326040.
PubMed
Abstract available
Psychological repercussions of breast or uterine cervical cancer disclosure to
women in Gabon.
PLoS One. 2025;20:e0326378.
PubMed
Abstract available
Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in
endocrine-resistant breast cancer cells.
PLoS One. 2025;20:e0326742.
PubMed
Abstract available
3Mont: A multi-omics integrative tool for breast cancer subtype stratification.
PLoS One. 2025;20:e0326154.
PubMed
Abstract available
Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using
near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed
model repeated measures design in patients with breast and gynecological cancer.
PLoS One. 2025;20:e0315351.
PubMed
Abstract available
Genome-scale knockout simulation and clustering analysis of drug-resistant breast
cancer cells reveal drug sensitization targets.
Proc Natl Acad Sci U S A. 2025;122:e2425384122.
PubMed
Abstract available
High-performance Open-source AI for Breast Cancer Detection and Localization in
MRI.
Radiol Artif Intell. 2025 Jun 25:e240550. doi: 10.1148/ryai.240550.
PubMed
Abstract available
Patient Perspectives on AI in Breast Cancer Screening: Reflections on Educational
Influence, Cognitive Bias, and Cultural Factors.
Radiol Imaging Cancer. 2025;7:e250243.
PubMed
Invasive Breast Cancers Missed by AI Screening of Mammograms.
Radiology. 2025;315:e242408.
PubMed
Abstract available
Erratum for: Preoperative Diagnosis of Ipsilateral and Contralateral Breast
Cancer: Role of Diffusion-weighted MRI.
Radiology. 2025;315:e259012.
PubMed
Breast cancer exosomes: Managing macrophage polarization and immune regulation in
the tumor microenvironment.
Semin Oncol. 2025;52:152365.
PubMed
Abstract available
Thank you for your interest in scientific medicine.